PSUSA/00002769/202506

Carmen Purdel elected as new chair of the Committee for Herbal Medicinal Products

Questions and answers about the clinical study data proof-of-concept pilot for industry

Questions and Answers on the 'OPEN' Framework

Human medicines European public assessment report (EPAR): Ponlimsi, denosumab, Date of authorisation: 17/11/2025, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Nyvepria, pegfilgrastim, Date of authorisation: 18/11/2020, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Libtayo, cemiplimab, Date of authorisation: 28/06/2019, Revision: 22, Status: Authorised

Human medicines European public assessment report (EPAR): Imnovid (previously Pomalidomide Celgene), pomalidomide, Date of authorisation: 05/08/2013, Revision: 26, Status: Authorised

Human medicines European public assessment report (EPAR): Hycamtin, topotecan, Date of authorisation: 12/11/1996, Revision: 42, Status: Authorised

PSUSA/00001506/202504